Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.
Venxxiva ™ (tiopronin delayed-release tablet) has been made available for the treatment of cystinuria.
An updated guideline has been published by the AHA, ACC, and other organizations regarding the management of acute coronary syndrome.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback